Feed AGNT
AG

eXp World Holdings, Inc. Common Stock AGNT · NASDAQ

$4.17 +5.57% (+$0.22)

Summary

41 / 100 · Bulios Score

What speaks for it

  • It has no debt and holds $111.2M in cash.
  • The share price is below the Bulios Fair Price.
  • It bought back its own shares for $56.2M in the last fiscal year, 8.1% of its market value.

What to watch

  • The company made a loss over the last 12 months.
  • Revenue growth is slowing: 1.3% a year over the last 3 years against 22% over 5 years.
  • It passes only 3 of the 9 points of the Piotroski financial health test.
  • It missed profit estimates 4 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $4.17

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 22% a year over 5 years. Over the last 3 years it grew by 1.3% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $17.2M.

Profitability in detail

Is it financially healthy?

Yes

It has no debt.

Financial health in detail

Does it pay a dividend?

Moderate, at risk
Yield
4.80%

You receive $0.20 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $6.5 is 56% above today's price. 50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy